The plaintiff's law firm said was the largest-ever sum awarded against J&J for a single plaintiff.

image for news J&J ordered to pay record $1.5B in talc cancer lawsuit — while vowing to appeal ‘unconstitutional' ruling

New York, NY, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a premier investment banking firm, today announced that Hyperscale Data, Inc. (NYSE American: GPUS) has entered into a sales agreement under which Spartan Capital Securities will act as the Company's sales agent for an at-the-market equity offering program.

image for news Spartan Capital Securities, LLC Serves as Sales Agent in Hyperscale Data, Inc.'s $50 Million At-the-Market Offering

SLF Stock Near 52-Week High: Time to Hold Despite Expensive Valuation? — Positive

SLF   Zacks Investment Research — December 23, 2025

Sun Life Financial stock gains from growing asset management businesses, its focus on Asia operations, as well as scaling up and integrating U.S. operations.

image for news SLF Stock Near 52-Week High: Time to Hold Despite Expensive Valuation?

2 Stocks for You to Buy From the Growing Outsourcing Market — Neutral

CGEMY  TNET   Zacks Investment Research — December 23, 2025

The rising demand for BPO, AI and ML drives the Zacks Outsourcing industry's growth. Increasing cybersecurity risks demand more outsourcing options.

image for news 2 Stocks for You to Buy From the Growing Outsourcing Market

RADNOR, Pa. , Dec. 23, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. ("CarMax") (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20, 2025, and November 5, 2025, inclusive (the "Class Period").

image for news CarMax, Inc. Investors: January 2, 2026 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit was filed on December 22, 2024 in the United States District Court for the District of Minnesota on behalf of all persons or entities who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).

image for news Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Inspire Medical Systems, Inc. (INSP)

Gold Mining ETF (GDXJ) Hits New 52-Week High — Neutral

GDXJ   Zacks Investment Research — December 23, 2025

GDXJ just broke to a new 52-week high as as gold demand surges on Fed rate-cut expectations, central bank buying and economic uncertainties.

image for news Gold Mining ETF (GDXJ) Hits New 52-Week High

CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies — Positive

CRSP   Zacks Investment Research — December 23, 2025

CRISPR Therapeutics shares jump after early zugo-cel study data show sustained B-cell depletion and early efficacy across autoimmune and cancer studies.

image for news CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies

Altria vs. Philip Morris: Who Leads Tobacco's Next Chapter? — Positive

MO  PM   Zacks Investment Research — December 23, 2025

MO and PM push smoke-free growth, using pricing power, innovation and discipline to navigate declining cigarette demand and reshape tobacco's future.

image for news Altria vs. Philip Morris: Who Leads Tobacco's Next Chapter?

Alibaba Stock Plunges 14.4% in 3 Months: Time to Buy, Sell or Hold? — Negative

BABA   Zacks Investment Research — December 23, 2025

BABA shares slides 14.4% in three months as profits crater despite revenue growth, with heavy AI and cloud spending testing investor patience.

image for news Alibaba Stock Plunges 14.4% in 3 Months: Time to Buy, Sell or Hold?

Bristol-Myers Squibb Company has rebounded solidly, as the market finally recognizes prior pessimism was excessive, driving renewed investor interest. Despite an estimated >60% revenue facing loss of exclusivity risks, BMY's growth portfolio delivered 18% growth in Q3 and now exceeds 50% of business mix. Robust free cash flow margins (>30%) and a 4.7% yield provide BMY investors with attractive compensation while awaiting pipeline catalysts.

image for news Bristol-Myers Squibb: Pharma Giant Still Undervalued And Printing Cash Despite Patent Cliff

Shipbuilding Stock Extends Record Highs on Trump Updates — Positive

HII   Schaeffers Research — December 23, 2025

Shipbuilding stock Huntington Ingalls Industries Inc (NYSE:HII) hit a fresh record high of $360.20 straight out of the gate, but was last seen trading near breakeven at $353.77.

image for news Shipbuilding Stock Extends Record Highs on Trump Updates

Bitcoin 2025 Recap: BTC Up 80% YTD Despite 30% Pullback From $126K Peak — Positive

ARKB  ARKW  BETE  BETH  BITB  BITC  BITO  BITQ  BITS  BITW  BLKC  BRRR  BTCO  BTCW  BTF  BTOP  DEFI  EZBC  FBTC  GBTC  HODL  IBIT  SATO  SPBC  STCE  WGMI  XBTF   24/7 Wall Street — December 23, 2025

Bitcoin's ( CRYPTO: BTC ) 2025 rally wasn't a straight line, which is what made it important.

image for news Bitcoin 2025 Recap: BTC Up 80% YTD Despite 30% Pullback From $126K Peak

Can Promises Alone Push Tesla to $2T in 2026? Here's Why Bulls Say Yes — Positive

TSLA   24/7 Wall Street — December 23, 2025

Tesla (NASDAQ:TSLA ) has been unbelievably bullish in the past few months.

image for news Can Promises Alone Push Tesla to $2T in 2026? Here's Why Bulls Say Yes

Copper Hits $12,000 a Ton. Time to Mine Freeport-McMoRan for More Profits? — Positive

FCX   24/7 Wall Street — December 23, 2025

Freeport-McMoRan (NYSE:FCX) shares rose 3% yesterday to close at $50.64 per share, putting them just 8% below the May 2024 high of $54.86 and about 16% shy of the company's all-time high just above $59 per share that it hit back in 2008.

image for news Copper Hits $12,000 a Ton. Time to Mine Freeport-McMoRan for More Profits?

JNJ's Tremfya Gets EU Approval for Pediatric Plaque Psoriasis — Positive

JNJ   Zacks Investment Research — December 23, 2025

Johnson & Johnson wins EU approval for Tremfya in pediatric plaque psoriasis, making it the first IL-23 inhibitor cleared for any pediatric condition.

image for news JNJ's Tremfya Gets EU Approval for Pediatric Plaque Psoriasis

Upstart's Partnerships Surge: Will it Ignite Revenue Rocket? — Positive

UPST   Zacks Investment Research — December 23, 2025

UPST expands partnerships with Tech CU, Peak and CAFCU, growing its AI lending network past 100 partners and widening personal, auto and HELOC offerings.

image for news Upstart's Partnerships Surge: Will it Ignite Revenue Rocket?

Is Amazon Stock Poised to Rally With AI Expansion in Cloud & Retail? — Positive

AMZN   Zacks Investment Research — December 23, 2025

AMZN stock is gaining momentum as AI investments boost AWS growth and enhance retail performance, driving revenue gains across both core businesses.

image for news Is Amazon Stock Poised to Rally With AI Expansion in Cloud & Retail?

Zacks Initiates Coverage of NGVC With Outperform Recommendation — Positive

NGVC   Zacks Investment Research — December 23, 2025

Find out why Zacks has given Natural Grocers an "Outperform" rating, being the first on Wall Street to initiate coverage on the stock. Explore how organic retail leadership, margin-boosting strategies, and wellness-driven demand fuel its growth potential.

image for news Zacks Initiates Coverage of NGVC With Outperform Recommendation

SHOP's Merchant Solutions Revenue Growth Picks Up: More Upside Ahead? — Positive

SHOP   Zacks Investment Research — December 23, 2025

Shopify's Merchant Solutions revenues surge 38.2% as GMV hits $92B, driven by B2B, Shop Pay and offline commerce strength.

image for news SHOP's Merchant Solutions Revenue Growth Picks Up: More Upside Ahead?